Showing 1–25 of 44 international scientific journals (Pharmacy)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Expert Opinion on Drug Discovery ISSN: 1746-0441 / 1746-045XTop Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 2 | 7.3 | 1.287Q1 | 50 | 75 | 1.7% | Informa Healthcare | Profile |
| 2 | Expert Opinion on Drug Delivery ISSN: 1742-5247Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 2 | 6 | 1.057Q1 | 88 | 72 | 4% | Taylor and Francis Ltd. | Profile |
| 3 | Expert Opinion on Therapeutic Targets ISSN: 1472-8222 / 1744-7631Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 5.1 | 1.383Q1 | 78 | 70 | 2.2% | Taylor and Francis Ltd. | Profile |
| 4 | Biomolecules & Therapeutics ISSN: 1976-9148 / 2005-4483 | 🌐South Korea | Q1 | CAS Tier 3 | 4.9 | 0.969Q2 | 26 | 93 | 6.7% | Korean Society of Applied Pharmacology | Profile |
| 5 | Molecular Pharmaceutics ISSN: 1543-8384 / 1543-8392 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.9 | 0.957Q1 | 110 | 384 | 6.7% | American Chemical Society | Profile |
| 6 | Advances in Therapy ISSN: 0741-238X / 1865-8652 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.7 | 1.418Q1 | 53 | 356 | 2.9% | Springer Healthcare | Profile |
| 7 | Expert Opinion on Therapeutic Patents ISSN: 1354-3776 / 1744-7674Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 4.7 | 1.098Q1 | 61 | 66 | 1.9% | Taylor and Francis Ltd. | Profile |
| 8 | Journal of Drug Targeting ISSN: 1061-186X / 1029-2330 | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 4.7 | 0.829Q1 | 80 | 80 | 0% | Informa Healthcare | Profile |
| 9 | Expert Review of Anti-Infective Therapy ISSN: 1478-7210 / 1744-8336Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 4.6 | 1.024Q1 | 65 | 116 | 2.4% | Taylor and Francis Ltd. | Profile |
| 10 | Pharmacological Reports ISSN: 1734-1140 / 2299-5684 | 🌐Poland | Q2 | CAS Tier 3 | 4.5 | 1.016Q1 | 71 | 135 | 0% | Springer International Publishing | Profile |
| 11 | Expert Opinion on Investigational Drugs ISSN: 1354-3784 / 1744-7658Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 4.3 | 1.199Q1 | 94 | 97 | 0% | Taylor and Francis Ltd. | Profile |
| 12 | Journal of Pharmacology and Experimental Therapeutics ISSN: 0022-3565 / 1521-0103 | 🇺🇸United States | Q2 | CAS Tier 3 | 4.3 | 0.921Q2 | 209 | 145 | 6.5% | American Society for Pharmacology and Experimental Therapeutics | Profile |
| 13 | Clinical Pharmacokinetics ISSN: 0312-5963 / 1179-1926 | 🌐New Zealand | Q2 | CAS Tier 2 | 4 | 1.211Q1 | 150 | 113 | 4.3% | Springer International Publishing | Profile |
| 14 | Naunyn-Schmiedebergs Archives of Pharmacology ISSN: 0028-1298 / 1432-1912 | 🇩🇪Germany | Q2 | CAS Tier 3 | 4 | 0.877Q2 | 83 | 134 | 6.5% | Springer Berlin Heidelberg | Profile |
| 15 | Pharmacotherapy ISSN: 0277-0008 / 1875-9114 | 🇺🇸United States | Q2 | CAS Tier 3 | 4 | 1.189Q1 | 99 | 102 | 6.9% | Wiley-Blackwell | Profile |
| 16 | Expert Opinion on Emerging Drugs ISSN: 1472-8214 / 1744-7623Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.8 | 0.908Q2 | 43 | 31 | 0% | Taylor and Francis Ltd. | Profile |
| 17 | Clinical Therapeutics ISSN: 0149-2918 / 1879-114X | 🇺🇸United States | Q2 | CAS Tier 3 | 3.7 | 1.041Q1 | 123 | 169 | 0% | Elsevier Inc. | Profile |
| 18 | Journal of Natural Products ISSN: 0163-3864 / 1520-6025Top Tier | 🇺🇸United States | Q2 | CAS Tier 2 | 3.7 | 0.585Q1 | 124 | 351 | 6.1% | American Chemical Society | Profile |
| 19 | Journal of Pharmacy and Pharmacology ISSN: 0022-3573 / 2042-7158 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.7 | 0.765Q2 | 107 | 193 | 0% | Wiley-Blackwell | Profile |
| 20 | Vascular Pharmacology ISSN: 1537-1891 / 1879-3649 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.7 | 0.99Q2 | 86 | 66 | 2.9% | Elsevier Inc. | Profile |
| 21 | Drug Metabolism and Disposition ISSN: 0090-9556 / 1521-009X | 🇺🇸United States | Q2 | CAS Tier 3 | 3.6 | 1.054Q1 | 161 | 99 | 15.9% | American Society for Pharmacology and Experimental Therapeutics | Profile |
| 22 | ChemMedChem ISSN: 1860-7179 / 1860-7187 | 🇩🇪Germany | Q2 | CAS Tier 3 | 3.5 | 0.67Q1 | 92 | 304 | 2.8% | John Wiley and Sons Ltd | Profile |
| 23 | Current Drug Targets ISSN: 1389-4501 / 1873-5592Top Tier | 🇳🇱Netherlands | Q2 | CAS Tier 4 | 3.5 | 0.726Q2 | 92 | 134 | 0% | Bentham Science Publishers B.V. | Profile |
| 24 | European Journal of Clinical Pharmacology ISSN: 0031-6970 / 1432-1041 | 🇩🇪Germany | Q2 | CAS Tier 3 | 3.5 | 0.886Q2 | 99 | 151 | 4.2% | Springer Berlin Heidelberg | Profile |
| 25 | AAPS Journal ISSN: 1550-7416 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.4 | 0.81Q1 | 96 | 114 | 4% | Springer International Publishing | Profile |